Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
Mahipal Sinnollareddy(University of South Australia), Despoina Koulenti(University of Thessaly), Jason A. Roberts(Université de Montpellier), Matteo Bassetti(Ospedale Policlinico San Martino), Jordi Rello(Centre Hospitalier Universitaire de Montpellier), Steven C. Wallis(The University of Queensland), Murat Akova(Hacettepe University), Philippe Montravers(Université Claude Bernard Lyon 1), Jeffrey Lipman(The University of Queensland), George Dimοpoulos(National and Kapodistrian University of Athens), Andrew Rhodes(St George's Hospital), Claude Martin(Assistance Publique Hôpitaux de Marseille), Jan J. De Waele(Ghent University Hospital), Kirsi-Maija Kaukonen(Helsinki University Hospital)
Cited by 143
Related Papers
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k